Print this page |
Categories |
 |
| Clinical Research Fellowship (CRF) | ||
| Early Career Development Fellowship (ECF) | ||
| International Clinical Research Fellowship (ICR) | ||
| Research Scholar Award (RSA) |
Round 1 2008
Awarded: $7,964,450. Funding Commencing 1 January 2009.
Full details of successful grants available at here.
Clinical Research Fellowship (CRF)
Application Number |
CIA Surname |
First Name |
Application Title |
Administering Institution |
Total $ Awarded |
|---|---|---|---|---|---|
08/CRF/1-04 |
Balleine |
Rosemary |
Molecular grade as prognostic indicator in invasive breast cancer |
University of Sydney |
$577,151 |
08/CRF/1-05 |
Buckland |
Michael |
Epigenetic changes in gliomas |
St Vincents Hospital |
$754,453 |
08/CRF/1-06 |
Sidhu |
Stan |
Molecular Markers of Diagnosis, Outcome and Therapeutic Response in Malignant Adrenal Tumours. |
University of Sydney |
$564,126 |
|
|
|
|
|
$1,895,730 |
Early Career Development Fellowship (ECF)
Application Number |
CIA Surname |
First Name |
Application Title |
Administering Institution |
Total $ Awarded |
|---|---|---|---|---|---|
08/ECF/1-10 |
Batten |
Marcel |
The importance of IL-27 signals for the anti-tumour immune response to lymphomas and mammary carcinomas. |
Garvan Institute of Medical Research |
$574,412 |
08/ECF/1-03 |
Don |
Anthony |
The molecular pathway for lymphoma cell death induced with the novel therapeutic FTY720. |
University of New South Wales |
$523,173 |
08/ECF/1-02 |
Howell |
Viive |
Ovarian cancer: Experimental models for understanding the molecular events important to this malignancy. |
University of Sydney |
$598,790 |
08/ECF/1-30 |
Kalinowski |
Danuta |
Development of Novel Anti-Cancer Drugs with Marked and Selective Activity that Overcome Resistance to Established Chemotherapy. |
University of Sydney |
$588,598 |
08/ECF/1-37 |
Phillips |
Phoebe |
Role of Heat Shock Proteins in Tumour-Stromal Interactions in Pancreatic Cancer. |
University of New South Wales |
$598,507 |
08/ECF/1-36 |
Suryo Rahmanto |
Yohan |
Novel insights into the role of melanoma tumour antigen p97 (melanotransferrin) in melanoma progression and pathogenesis. |
University of Sydney |
$593,197 |
08/ECF/1-12 |
Swarbrick |
Alexander |
The role of the miR-379-656 microRNA cluster in cancer. |
Garvan Institute of Medical Research |
$593,996 |
08/ECF/1-18 |
Wolfenden |
Luke |
Supporting parents to increase children’s consumption of fruits and vegetables: a randomised controlled trial of a telephone based intervention. |
University of Newcastle |
$586,101 |
08/ECF/1-08 |
Yu |
Di |
Anti-tumour helper T cells: the role of IL-21 and novel approaches for cancer therapy. |
University of New South Wales |
$587,680 |
|
|
|
|
|
$5,244,454 |
TopInternational Clinical Research Fellowship (ICR)
Application Number |
CIA Surname |
First Name |
Application Title |
Administering Institution |
Total $ Awarded |
|---|---|---|---|---|---|
08/ICR/1-03 |
Lee |
Mi Joung |
Lower limb lymphoedema secondary to cancer treatment. |
University of Sydney |
$158,961 |
|
|
|
|
|
$158,961 |
Research Scholar Award (RSA)
Application Number |
CIA Surname |
First Name |
Application Title |
Administering Institution |
Total $ Awarded |
|---|---|---|---|---|---|
08/RSA/1-38 |
Blinman |
Prunella |
Determining patients and doctors preferences for chemotherapy and incorporating them into clinical decision making. |
University of Sydney |
$35,000 |
08/RSA/1-44 |
Bryant |
Jamie |
'Tackling Tobacco: An exploration of methods to reduce smoking in socially disadvantaged populations. |
University of Newcastle |
$55,305 |
08/RSA/1-15 |
Chang |
David |
Biomarkers of phenotype, prognosis and response to therapy in pancreatic cancer. |
Garvan Institute of Medical Research |
$50,000 |
08/RSA/1-16 |
Fardell |
Joanna |
Chemotherapy and cognitive decline: Is exercise a remedy? |
University of Sydney |
$50,000 |
08/RSA/1-09 |
Junankar |
Simon |
Recognition of senescent cancer cells by the immune system. |
Garvan Institute of Medical Research |
$50,000 |
08/RSA/1-37 |
Kaul |
Zeenia |
Defining the role of telomere dysfunction in cellular proliferation barriers. |
Children’s Medical Research Institute |
$50,000 |
08/RSA/1-18 |
Lavis |
Christopher |
The role of dysregulation of CHOP in adaptation of human melanoma cells to endoplasmic reticulum (ER) stress. |
University of Newcastle |
$50,000 |
08/RSA/1-39 |
Ong |
Vivienna |
The Role of the Grb7 Adaptor Protein in Pancreatic Cancer. |
Garvan Institute of Medical Research |
$50,000 |
08/RSA/1-13 |
Payne |
Cathy |
Oligodendrogliomas with LOH 1p19q: Identifying Genes associated with Therapeutic Chemosensitivity. |
University of Sydney |
$50,000 |
08/RSA/1-02 |
Penfold |
Scott |
Development of Proton Computed Tomography for Application in Proton Radiation Therapy. |
University of Wollongong |
$25,000 |
08/RSA/1-36 |
Sharbeen |
George |
Selective killing of mismatch repair deficient cancer cells. |
Centenary Institute of Cancer Medicine and Cell Biology |
$25,000 |
08/RSA/1-07 |
Shelley |
Elizabeth |
Preclinical studies of a novel plant toxin, persin, as an anti-cancer agent. |
Garvan Institute of Medical Research |
$50,000 |
08/RSA/1-22 |
Tacon |
Lyndall |
Molecular mechanisms of adrenocortical tumorigenesis and response to therapy. |
University of Sydney |
$50,000 |
08/RSA/1-32 |
Walker |
Sarah |
The Role of Adiponectin in Hepatocellular Carcinoma. |
University of Sydney |
$75,000 |
|
|
|
|
|
$665,305 |
